Transform Wealth, LLC Vertex Pharmaceuticals Inc Transaction History

Transform Wealth, LLC

$1.02 Billion
Q1 2024

A detailed history of Transform Wealth, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Transform Wealth, LLC holds 23,089 shares of VRTX stock, worth $11.2 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

23,089

Previous 22,327 3.41%

Holding current value

$11.2 Million

Previous $9.08 Million 6.24%

% of portfolio

0.94%

Previous 0.91%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$407.69 - $446.08 $310,659 - $339,912	762 Added 3.41%	23,089 $9.65 Million
Q4 2023 Jan 18, 2024	BUY	$343.0 - $410.68 $105,644 - $126,489	308 Added 1.4%	22,327 $9.08 Million
Q3 2023 Oct 10, 2023	BUY	$338.18 - $362.46 $28,745 - $30,809	85 Added 0.39%	22,019 $7.66 Million
Q2 2023 Jul 13, 2023	SELL	$314.42 - $351.91 $59,739 - $66,862	-190 Reduced 0.86%	21,934 $7.72 Million
Q1 2023 Apr 14, 2023	SELL	$283.23 - $323.1 $28,889 - $32,956	-102 Reduced 0.46%	22,124 $6.97 Million

Q4 2022 Jan 12, 2023	BUY	$285.76 - $321.48 $1.58 Million - $1.78 Million	5,530 Added 33.12%	22,226 $0
Q3 2022 Oct 21, 2022	BUY	$273.83 - $305.53 $410,471 - $457,989	1,499 Added 9.86%	16,696 $4.83 Million
Q2 2022 Jul 15, 2022	BUY	$234.96 - $292.55 $3.57 Million - $4.45 Million	15,197 New	15,197 $4.28 Million
Q2 2021 Jul 20, 2021	SELL	$187.49 - $221.1 $2.25 Million - $2.65 Million	-11,985 Closed	0 $0
Q1 2021 Apr 22, 2021	BUY	$207.02 - $241.31 $180,314 - $210,181	871 Added 7.84%	11,985 $2.58 Million
Q4 2020 Jan 20, 2021	BUY	$207.01 - $276.09 $2.3 Million - $3.07 Million	11,114 New	11,114 $2.63 Million

Others Institutions Holding VRTX

# of Institutions

1,625

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $125B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transform Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transform Wealth, LLC with notifications on news.

Account

Transform Wealth, LLC Vertex Pharmaceuticals Inc Transaction History